Australia's ECS Botanics rises on medicinal cannabis products deal

ECS Botanics Holdings

17/05/2024 05:21

** Shares of ECS Botanics  ECS.AX  rise as much as 5.6% to
A$0.019, their highest level since May 8
    ** The medical cannabis co secures its first
direct-to-consumer medicinal cannabis sales contract
    ** Co enters agreement with Elite Medical Solutions to
retail ECS medicinal cannabis soft gel capsules and oral liquids
    ** Says Elite Medical Solutions will sell a minimum annual
order quantity of A$380,000 ($253,156)
    ** ECS stock down 20% YTD, as of last close 
   

   ($1 = 1.5011 Australian dollars)

 (Reporting by John Biju in Bengaluru)
 ((John.Biju@thomsonreuters.com;))